Tenderwize
Back to tender search

Denosumab (60mg) Discount Agreement

Techniker Krankenkasse·Hamburg, Germany·Deadline Nov 29, 2027 · 468 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 19 - Denosumab (Wirkstärke 60mg)

45/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

45 / 100

Complexity

40 / 100

Risk factors

Non-compliance with eligibility criteria (e.g., authorization status) could lead to contract invalidation. Self-declara...

No estimated value or volume provided; actual revenue from this agreement is uncertain. Low prescription volumes could...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Nov 2027
  • Supply of Denosumab (strength 60mg) pharmaceutical products
  • Conclusion of discount agreements with TK and participating health insurances
Show full summary

Open House discount agreement (Rabattvertrag) for Denosumab (strength 60mg) with the Techniker Krankenkasse (TK) and participating health insurances (HEK, hkk). The procedure is a non-competitive Open House with uniform conditions, no exclusivity, and maximum 17-month duration (1 July 2026 to 30 November 2027). All qualified pharmaceutical entrepreneurs can join at any time. No estimated value is provided.

Risks

Non-compliance with eligibility criteria (e.g., authorization status) could lead to contract invalidation. Self-declara...

No estimated value or volume provided; actual revenue from this agreement is uncertain. Low prescription volumes could...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as per § 4 Abs. 18 AMG with valid authorization
  • Must have a registered seat in Germany, EU, or EEA

Administrative

  • Must provide self-declaration regarding authorization and reliability

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Denosumab (60mg) Discount Agreement

Open House agreement for Denosumab 60mg discount contracts under § 130a Abs. 8 SGB V. Supply of pharmaceutical product with no exclusivity. Maximum 17 months from 1 July 2026 to 30 November 2027.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jun 2026 - Nov 2027

Category

Pharmaceutical products

Deadline

Deadline Nov 29, 2027

Procurement Details

Publication date
25 May 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
354637-2026

Documents (1)

Similar tenders